ALISO VIEJO, Calif.,
May 28, 2014 /PRNewswire/ --
Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced
that company management will present an overview of the company at
the following conferences in June.
- Jefferies 2014 Global Healthcare Conference
- Presentation date: Tuesday, June 3,
2014
- Presentation time: 3:30 p.m.
E.T.
- The JMP Securities Healthcare Conference
- Presentation date: Tuesday, June 24,
2014
- Presentation time: 10:00 a.m.
E.T.
A live webcast and 30-day archive of these presentations will be
available at http://ir.avanir.com.
About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company
focused on bringing innovative medicines to patients with central
nervous system disorders of high unmet medical need. As part of our
commitment, we have extensively invested in our pipeline and are
dedicated to advancing medicines that can substantially improve the
lives of patients and their loved ones. For more information about
Avanir, please visit www.avanir.com.
AVANIR® is a trademark or registered trademark of Avanir
Pharmaceuticals, Inc. in the United
States and other countries.
©2014 Avanir Pharmaceuticals, Inc. All Rights Reserved.
Avanir Investor & Media Contact
Ian Clements, PhD
ir@avanir.com
+1 (949) 389-6700
Logo -
http://photos.prnewswire.com/prnh/20130207/LA55901LOGO
SOURCE Avanir Pharmaceuticals, Inc.